Nanoparticles for brain-specific drug and genetic material delivery, imaging and diagnosis

Nanomedicine (Lond). 2016 Apr;11(7):833-49. doi: 10.2217/nnm.16.15. Epub 2016 Mar 16.

Abstract

The poor access of therapeutic drugs and genetic material into the central nervous system due to the presence of the blood-brain barrier often limits the development of effective noninvasive treatments and diagnoses of neurological disorders. Moreover, the delivery of genetic material into neuronal cells remains a challenge because of the intrinsic difficulty in transfecting this cell type. Nanotechnology has arisen as a promising tool to provide solutions for this problem. This review will cover the different approaches that have been developed to deliver drugs and genetic material efficiently to the central nervous system as well as the main nanomaterials used to image the central nervous system and diagnose its disorders.

Keywords: blood–brain barrier; brain; drug delivery; imaging; nanoparticles; siRNA.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Brain / drug effects
  • Brain / metabolism
  • Brain / pathology*
  • Brain Diseases / diagnosis*
  • Brain Diseases / genetics
  • Brain Diseases / therapy*
  • Drug Carriers / analysis*
  • Drug Carriers / metabolism
  • Drug Delivery Systems / methods*
  • Gene Transfer Techniques*
  • Humans
  • Nanomedicine / methods
  • Nanoparticles / analysis*
  • Nanoparticles / metabolism
  • Nanotechnology / methods

Substances

  • Drug Carriers